MESP1 Mutations in Patients with Congenital Heart Defects.
MESP1 Mutations in Patients with Congenital Heart Defects.
复制标题
DOI：
10.1002/humu.22947
复制
发表时间：
2016-03
期刊：
影响因子：
3.9
通讯作者：
Goldmuntz E
中科院分区：
文献类型：
--
作者：
Werner P;Latney B;Deardorff MA;Goldmuntz E
Identifying the genetic etiology of congenital heart disease (CHD) has been challenging despite being one of the most common congenital malformations in humans. We previously identified a microdeletion in a patient with a ventricular septal defect containing over 40 genes including MESP1 (mesoderm posterior bHLH transcription factor 1). Because of the importance of MESP1 as an early regulator of cardiac development in both in vivo and in vitro studies, we tested for MESP1 mutations in 647 patients with congenital conotruncal and related heart defects. We identified six rare, non-synonymous variants not seen in ethnically matched controls and one likely race-specific non-synonymous variant. Functional analyses revealed that three of these variants altered activation of transcription by MESP1. Two of the deleterious variants are located within the conserved HLH domain and thus impair the protein-protein interaction of MESP1 and E47. The third deleterious variant was a loss of function frameshift mutation. Our results suggest that pathologic variants in MESP1 may contribute to the development of CHD and that additional protein partners and downstream targets could likewise contribute to the wide range of causes for CHD.
